DeFronzo R A, Ferrannini E, Hendler R, Wahren J, Felig P
Proc Natl Acad Sci U S A. 1978 Oct;75(10):5173-7. doi: 10.1073/pnas.75.10.5173.
The effects of hyperinsulinemia, hyperglycemia, and the route of glucose administration on total glucose utilization and on net splanchnic glucose exchange were studied in 20 normal volunteers with the hepatic venous catheter technique. Euglycemic hyperinsulinemia [induced by a priming plus continuous infusion of insulin resulting in plasma insulin levels of 400-1200 muunits (international)/ml and a variable glucose infusion] caused a 5- to 6-fold increase above basal in total glucose turnover. However, net splanchnic glucose uptake (0.5 +/- 0.2 mg/kg per min) accounted for only 4-5% of total glucose utilization. When hyperglycemia (223 +/- 1 mg/dl) was induced in addition to hyperinsulinemia by the intravenous infusion of glucose, splanchnic glucose uptake increased 100% to 1.0-1.1 mg/kg per min but was still responsible for only 10-14% of total glucose utilization. In other studies hyperglycemia (223 +/- 2 mg/dl) was maintained constant by a variable intravenous infusion of glucose for 4 hr and oral glucose (1.2 gm/kg) was administered at 1 hr. After the oral glucose, net splanchnic glucose uptake increased to values 6-fold higher than with intravenous glucose despite unchanged plasma glucose levels and plasma insulin concentrations well below those observed in the studies with euglycemic hyperinsulinemia. The results indicate that hyperinsulinemia or hyperglycemia induced by intravenous infusion of glucose or insulin causes minimal net uptake of glucose by the splanchnic bed despite marked stimulation of total glucose turnover. In contrast, administration of glucose by the oral route has a marked stimulatory effect on net splanchnic glucose uptake. These findings suggest that orally consumed glucose causes the release of a gastrointestinal factor that enhances insulin-mediated glucose uptake by the liver.
采用肝静脉导管技术,在20名正常志愿者中研究了高胰岛素血症、高血糖以及葡萄糖给药途径对总葡萄糖利用和内脏葡萄糖净交换的影响。正常血糖高胰岛素血症(通过胰岛素的起始剂量加持续输注诱导,使血浆胰岛素水平达到400 - 1200微单位(国际单位)/毫升,并进行可变的葡萄糖输注)导致总葡萄糖周转率比基础值增加5至6倍。然而,内脏葡萄糖净摄取量(0.5±0.2毫克/千克每分钟)仅占总葡萄糖利用量的4 - 5%。当通过静脉输注葡萄糖在高胰岛素血症基础上诱发高血糖(223±1毫克/分升)时,内脏葡萄糖摄取量增加100%,达到1.0 - 1.1毫克/千克每分钟,但仍仅占总葡萄糖利用量的10 - 14%。在其他研究中,通过可变的静脉输注葡萄糖使高血糖(223±2毫克/分升)持续4小时,并在1小时时给予口服葡萄糖(1.2克/千克)。口服葡萄糖后,尽管血浆葡萄糖水平未变且血浆胰岛素浓度远低于正常血糖高胰岛素血症研究中观察到的水平,但内脏葡萄糖净摄取量增加到比静脉输注葡萄糖时高6倍的值。结果表明,静脉输注葡萄糖或胰岛素诱发的高胰岛素血症或高血糖,尽管会显著刺激总葡萄糖周转率,但内脏床的葡萄糖净摄取量极少。相比之下,口服葡萄糖对内脏葡萄糖净摄取有显著的刺激作用。这些发现提示,口服的葡萄糖会促使一种胃肠因子释放,该因子可增强肝脏胰岛素介导的葡萄糖摄取。